• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Thursday, September 18, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Antidepressants reduce deaths by more than a third in patients with diabetes

Bioengineer by Bioengineer
July 2, 2019
in Health
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

WASHINGTON–Antidepressants reduce deaths by more than a third in patients with diabetes and depression, according to a study published in the Endocrine Society’s Journal of Clinical Endocrinology & Metabolism.

People with diabetes are two to three times more likely to have depression than people without diabetes, according to the U.S. Centers for Disease Control and Prevention. Half to three-quarters of people with diabetes and depression go undiagnosed, despite therapy and medicine being very effective.

“The incidence of major depressive disorder amongst individuals with diabetes is significantly greater than the general population,” said the study’s corresponding author, Vincent Chin-Hung Chen, Professor, of Chiayi Chang Gung Memorial Hospital and Chang Gung University in Puzi, Taiwan. “Diabetes and depression each independently contribute to increasing total mortality.”

In this large population-based study, researchers used the National Health Insurance Research Database in Taiwan to identify 53,412 patients diagnosed with diabetes and depression since 2000. The researchers followed this population until 2013 to see if antidepressants reduced the death rate. They found that antidepressants significantly reduced mortality by 35 percent.

“This data provides further rationale for the screening and treating of depression in persons who have diabetes,” Chen said.

###

Other authors of the study include: Hong-Ming Chen of Chiayi Chang Gung Memorial Hospital and Chang Gung University; Yao-Hsu Yang and Ko-Jung Chen of Chang Gung Memorial Hospital in Chiayi, Taiwan; Yena Lee and Roger S. McIntyre of University Health Network in Toronto, Ontario, Canada; Mong-Liang Lu of Taipei Medical University in Taipei, Taiwan; Yi-Chen Lee of Chiayi Chang Gung Memorial Hospital; and Ming-Chia Hsieh of China Medical University, China Medical University Hospital and Changhua Christian Hospital in Taiwan.

The study received funding support from Changhua Christian Hospital.

The study, “Antidepressants Reduced Risk of Mortality in Patients with Diabetes Mellitus: A Population-Based Cohort Study in Taiwan,” will be published online, ahead of print.

Endocrinologists are at the core of solving the most pressing health problems of our time, from diabetes and obesity to infertility, bone health, and hormone-related cancers. The Endocrine Society is the world’s oldest and largest organization of scientists devoted to hormone research and physicians who care for people with hormone-related conditions.

The Society has more than 18,000 members, including scientists, physicians, educators, nurses and students in 122 countries. To learn more about the Society and the field of endocrinology, visit our site at http://www.endocrine.org. Follow us on Twitter at @TheEndoSociety and @EndoMedia.

Media Contact
Jenni Glenn Gingery
[email protected]
http://dx.doi.org/10.1210/jc.2018-02362

Tags: Depression/AngerDiabetesEndocrinologyHealth ProfessionalsInternal MedicineMedicine/HealthMental HealthMetabolism/Metabolic Diseases
Share12Tweet8Share2ShareShareShare2

Related Posts

Vitamins’ Role and Mechanisms in Obesity Control

September 18, 2025

Engineered Prime Editors Minimize Genomic Errors

September 18, 2025

New Study Confronts the Cardiovascular Impact of COVID-19 Head-On

September 18, 2025

Groundbreaking Report Reveals Strategies to Address COVID-19’s Lasting Impact on Cardiovascular Health

September 18, 2025
Please login to join discussion

POPULAR NEWS

  • blank

    Breakthrough in Computer Hardware Advances Solves Complex Optimization Challenges

    155 shares
    Share 62 Tweet 39
  • New Drug Formulation Transforms Intravenous Treatments into Rapid Injections

    117 shares
    Share 47 Tweet 29
  • Physicists Develop Visible Time Crystal for the First Time

    67 shares
    Share 27 Tweet 17
  • Tailored Gene-Editing Technology Emerges as a Promising Treatment for Fatal Pediatric Diseases

    48 shares
    Share 19 Tweet 12

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Vitamins’ Role and Mechanisms in Obesity Control

Engineered Prime Editors Minimize Genomic Errors

New Study Confronts the Cardiovascular Impact of COVID-19 Head-On

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.